Rayner set to launch RayOne® at the XXXIV Congress of the ESCRS
Following the recent receipt of CE mark approval, Rayner are proud to announce the launch of RayOne®: their fully preloaded IOL injection system to be unveiled at the upcoming ESCRS in Copenhagen.
This flagship launch is the second in the pipeline of 11 new products which Rayner plan to launch over the next 3 years, a testament to Rayner’s renewed commitment to transform into one of the leading manufacturers of IOLs, all with the ambition of delivering better patient outcomes.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.